We are live on ! Find out more
VMD icon

Viemed Healthcare

96 hedge funds and large institutions have $149M invested in Viemed Healthcare in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 35 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

4% more funds holding

Funds holding: 9296 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3.09% less ownership

Funds ownership: 47.2%44.11% (-3.1%)

15% less capital invested

Capital invested by funds: $174M → $149M (-$25.7M)

20% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 35

Holders
96
Holders Change
+4
Holders Change %
+4.35%
% of All Funds
1.94%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
28
Reduced
35
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$19M +$4.05M +401,037 +22%
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$13.5M +$2.79M +276,420 +22%
NCM
3
Nantahala Capital Management
Connecticut
$13M
Fidelity Investments
4
Fidelity Investments
Massachusetts
$11.3M -$55.9K -5,539 -0.4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$10.7M -$139K -13,736 -1%
AIC
6
AWM Investment Company
New York
$9.41M -$2.25M -223,123 -17%
Goldman Sachs
7
Goldman Sachs
New York
$6.98M +$1.69M +167,672 +26%
HIM
8
Hillsdale Investment Management
Ontario, Canada
$6.47M -$8.81M -873,644 -54%
Connor, Clark & Lunn Investment Management (CC&L)
9
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.94M +$795K +78,840 +16%
CSC
10
Cove Street Capital
California
$4.82M -$855K -84,800 -13%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$4.56M -$668K -66,200 -11%
State Street
12
State Street
Massachusetts
$3.87M +$345K +34,237 +8%
Northern Trust
13
Northern Trust
Illinois
$2.85M -$148K -14,623 -4%
RA
14
Raffles Associates
New York
$2.78M -$2.02M -200,000 -38%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.23M +$206K +20,461 +9%
Wells Fargo
16
Wells Fargo
California
$1.8M +$1.91M +189,444 +1,001%
JP Morgan Chase
17
JP Morgan Chase
New York
$1.75M +$1.23M +121,504 +170%
RA
18
Royce & Associates
New York
$1.6M
Two Sigma Investments
19
Two Sigma Investments
New York
$1.45M +$427K +42,298 +34%
BCIM
20
British Columbia Investment Management
British Columbia, Canada
$1.32M -$1.31M -129,568 -46%
PIC
21
PCJ Investment Counsel
Ontario, Canada
$1.17M +$403K +39,980 +42%
UIC
22
Uniplan Investment Counsel
Wisconsin
$1.16M -$9.72K -964 -0.7%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$1.14M -$244K -24,200 -15%
Deutsche Bank
24
Deutsche Bank
Germany
$958K +$944K +93,566 +538%
1832 Asset Management
25
1832 Asset Management
Ontario, Canada
$911K -$2.65M -262,900 -72%

VMD Hedge Fund Activity: Q3 2020 in Review

96 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2020, worth a combined $149M — down 15% from $174M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new VMD positions and 12 closed out — a net gain of 4 holders — while 28 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock, adding an estimated $4.05M. The largest seller was Hillsdale Investment Management, cutting an estimated $8.81M.

  • 96 institutional investors held Viemed Healthcare (VMD) as of Q3 2020, up from 92 in Q2 2020.
  • Funds reported $149M of Viemed Healthcare stock for Q3 2020, down 15% quarter-over-quarter.
  • 16 funds opened new Viemed Healthcare positions in Q3 2020 and 12 closed out, a net change of +4 holders.
  • The largest Viemed Healthcare buyer in Q3 2020 was BlackRock, an estimated $4.05M added.
  • The largest Viemed Healthcare seller in Q3 2020 was Hillsdale Investment Management, an estimated $8.81M sold.

Based on aggregated 13F filings for Q3 2020.